176 related articles for article (PubMed ID: 8788915)
1. Chronic haloperidol-induced changes in regional dopamine release and metabolism and neurotensin content in rats.
See RE; Lynch AM; Aravagiri M; Nemeroff CB; Owens MJ
Brain Res; 1995 Dec; 704(2):202-9. PubMed ID: 8788915
[TBL] [Abstract][Full Text] [Related]
2. Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not prefrontal cortex.
See RE; Lynch AM
Neuroreport; 1995 Sep; 6(13):1795-8. PubMed ID: 8541484
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen.
Pehek EA; Yamamoto BK
J Neurochem; 1994 Dec; 63(6):2118-24. PubMed ID: 7964731
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.
Yamamoto BK; Cooperman MA
J Neurosci; 1994 Jul; 14(7):4159-66. PubMed ID: 7913120
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of haloperidol on dopamine release and metabolism in caudate putamen and anteromedial frontal cortex using intracerebral dialysis.
Kurata K; Shibata R
Pharmacology; 1991; 42(1):1-9. PubMed ID: 2057516
[TBL] [Abstract][Full Text] [Related]
6. Subchronic administration of clozapine, but not haloperidol or metoclopramide, decreases dopamine D2 receptor messenger RNA levels in the nucleus accumbens and caudate-putamen in rats.
See RE; Lynch AM; Sorg BA
Neuroscience; 1996 May; 72(1):99-104. PubMed ID: 8730709
[TBL] [Abstract][Full Text] [Related]
7. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
Prus AJ; Huang M; Li Z; Dai J; Meltzer HY
Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic antipsychotic drug treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat.
Marcus MM; Nomikos GG; Malmerfelt A; Zachrisson O; Lindefors N; Svensson TH
Brain Res Mol Brain Res; 1997 May; 45(2):275-82. PubMed ID: 9149102
[TBL] [Abstract][Full Text] [Related]
9. Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats.
See RE; Chapman MA; Klitenick MA
Brain Res; 1992 Aug; 588(1):177-80. PubMed ID: 1356587
[TBL] [Abstract][Full Text] [Related]
10. Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration.
Kurachi M; Shibata R; Murata M; Tanii Y
Biol Psychiatry; 1995 Apr; 37(7):487-90. PubMed ID: 7786966
[No Abstract] [Full Text] [Related]
11. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum.
Pehek EA
J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982
[TBL] [Abstract][Full Text] [Related]
12. Regulation of extracellular dopamine by the norepinephrine transporter.
Yamamoto BK; Novotney S
J Neurochem; 1998 Jul; 71(1):274-80. PubMed ID: 9648875
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin, N-acetyl-aspartylglutamate and beta-endorphin modulate [3H]dopamine release from guinea pig nucleus accumbens, prefrontal cortex and caudate-putamen.
Weatherspoon JK; Frank AR; Werling LL
Neuropeptides; 1996 Oct; 30(5):497-505. PubMed ID: 8923514
[TBL] [Abstract][Full Text] [Related]
14. Distinct and interactive effects of d-amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat.
Zahm DS; Williams ES; Krause JE; Welch MA; Grosu DS
J Comp Neurol; 1998 Nov; 400(4):487-503. PubMed ID: 9786410
[TBL] [Abstract][Full Text] [Related]
15. The sigma receptor ligand SR 31742A increases neurotensin in the nucleus accumbens but not in the caudate-putamen of the rat.
Labie C; Keane PE; Soubrié P; Le Fur G
Eur J Pharmacol; 1993 Feb; 231(3):465-7. PubMed ID: 8095466
[TBL] [Abstract][Full Text] [Related]
16. Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment.
Amato D; Natesan S; Yavich L; Kapur S; Müller CP
Int J Neuropsychopharmacol; 2011 Nov; 14(10):1327-39. PubMed ID: 21281560
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
[TBL] [Abstract][Full Text] [Related]
18. Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function.
Alonso R; Voutsinos B; Fournier M; Labie C; Steinberg R; Souilhac J; Le Fur G; Soubrié P
Neuroscience; 1999; 91(2):607-20. PubMed ID: 10366018
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in chronic neuroleptic effects on extracellular dopamine activity.
See RE; Chapman MA; Murray CE; Aravagiri M
Brain Res Bull; 1992; 29(3-4):473-8. PubMed ID: 1382815
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis.
Wagstaff JD; Gibb JW; Hanson GR
Brain Res; 1996 May; 721(1-2):196-203. PubMed ID: 8793101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
